[PDF][PDF] Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a …
…, Á Pecondón, S Ojeda, JC Quevedo… - Arthritis Care & …, 2020 - Wiley Online Library
Objective To evaluate the impact of comorbidities on physical function in patients with
ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Methods This was a cross‐sectional …
ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Methods This was a cross‐sectional …
What is the diagnostic value of ultrasonography compared to physical evaluation in patients with idiopathic carpal tunnel syndrome?
…, F Francisco, JC Quevedo, C Erausquin - Clinical and …, 2007 - accedacris.ulpgc.es
OBJECTIVE: Our hypothesis is that sonography performed by the rheumatologist in patients
with suspected carpal tunnel syndrome (CTS) has higher diagnostic value compared to …
with suspected carpal tunnel syndrome (CTS) has higher diagnostic value compared to …
Lipoprotein (a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
…, C Erausquin, S Ojeda, JC Quevedo… - Journal of Clinical …, 2017 - Elsevier
Background Plasma concentrations of lipoprotein (a) (Lp(a)), a lipoprotein with atherogenic
and thrombogenic properties, have a strong genetic basis, although high concentrations of …
and thrombogenic properties, have a strong genetic basis, although high concentrations of …
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the …
…, C Erausquin, Í Rúa, JC Quevedo… - British Journal of …, 2017 - academic.oup.com
Background Information on the safety of tumour necrosis factor (TNF) antagonists frequently
arises from their use in rheumatic diseases, their first approved indications, and is later …
arises from their use in rheumatic diseases, their first approved indications, and is later …
Clinical and immunogenetic factors associated with pneumonia in patients with systemic lupus erythematosus: a case-control study
…, E Herrera-Ramos, S Ojeda, JC Quevedo… - The Journal of …, 2014 - jrheum.org
Objective. To determine the incidence of pneumonia and associated factors in a single-center
systemic lupus erythematosus (SLE) cohort. Methods. We included all our SLE patients […
systemic lupus erythematosus (SLE) cohort. Methods. We included all our SLE patients […
[HTML][HTML] Irisin as a novel biomarker of subclinical atherosclerosis, cardiovascular risk and severe disease in axial spondyloarthritis
…, O Gualillo, JC Quevedo-Abeledo… - Frontiers in …, 2022 - frontiersin.org
Introduction Patients with axial spondyloarthritis (axSpA) have a high disease burden mainly
due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads …
due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads …
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
H Sánchez-Pérez, JC Quevedo-Abeledo… - …, 2020 - academic.oup.com
Objectives Lipid profiles appear to be altered in SLE patients due to disease activity and
inflammation. Cholesterol efflux capacity (CEC) is the ability of high-density lipoprotein …
inflammation. Cholesterol efflux capacity (CEC) is the ability of high-density lipoprotein …
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients
…, JC Quevedo-Abeledo, C Rodríguez-Lozano… - Seminars in Arthritis and …, 2023 - Elsevier
Objectives To determine the potential impact of sex-specific disease-related characteristics
on cardiovascular (CV) disease in axial spondyloarthritis (axSpA). Methods Cross-sectional …
on cardiovascular (CV) disease in axial spondyloarthritis (axSpA). Methods Cross-sectional …
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
…, JC Quevedo-Abeledo, C Rodríguez-Lozano… - Seminars in Arthritis and …, 2021 - Elsevier
Objectives To compare the atherosclerosis disease burden between ankylosing spondylitis (AS)
and non-radiographic (nr) axial spondyloarthritis (axSpA) and establish a model that …
and non-radiographic (nr) axial spondyloarthritis (axSpA) and establish a model that …
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
…, JC Quevedo-Abeledo, C Rodríguez-Lozano… - Seminars in Arthritis and …, 2022 - Elsevier
Objectives To identify disease-related factors associated with subclinical atherosclerosis
and cardiovascular (CV) events in a large series of patients with axial spondyloarthritis (axSpA) …
and cardiovascular (CV) events in a large series of patients with axial spondyloarthritis (axSpA) …